Dianthus Therapeutics (DNTH) Superinvestor holders
13 of the superinvestors we track hold Dianthus Therapeutics (DNTH) in their latest 13F filings, $327M in total.
Summary
The largest holder is Alger (Fred Alger Management), with $127M, 0.4% of the portfolio.
In their latest quarter: 3 opened a new position, 4 added, 6 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Alger Fred Alger Management |
Added | 1,302,493 | $127M | 0.4% | Q2 2026 |
| Jennison Associates | Added | 1,021,763 | $100M | 0.1% | Q2 2026 |
| Artisan Partners | Trimmed | 258,269 | $25M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 272,863 | $24M | 0.0% | Q3 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 174,187 | $17M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 128,743 | $13M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 107,455 | $10M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 42,928 | $4M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 37,308 | $4M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 18,205 | $2M | 0.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
Added | 9,333 | $909,781 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 2,974 | $289,906 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 327 | $28,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 12 |
| Q1 2026 | 13 |
| Q4 2025 | 11 |
| Q3 2025 | 8 |
| Q2 2025 | 2 |
| Q1 2025 | 1 |
| Q4 2024 | 2 |
| Q3 2024 | 5 |
Questions about Dianthus Therapeutics
Which superinvestors own Dianthus Therapeutics?
13 of the superinvestors we track hold Dianthus Therapeutics (DNTH) in their latest 13F filings, $327M in total. Alger, Jennison Associates, Artisan Partners, Ken Fisher, Ensign Peak, Paul Marshall.
Who is the largest superinvestor holder of DNTH?
The largest holder is Alger (Fred Alger Management), with $127M, 0.4% of the portfolio.
From Dianthus Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.